N-[3-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-[di(propan-2-yl)carbamoyl]phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N,N-di(propan-2-yl)-3-[[4-(propan-2-ylsulfonylamino)benzoyl]amino]benzamide;N-[4-(2-oxopiperidin-1-yl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;4-(propan-2-ylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]benzamide

C124H158F3N19O25S9 — CID 157309512

IUPACN-[3-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-[di(propan-2-yl)carbamoyl]phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N,N-di(propan-2-yl)-3-[[4-(propan-2-ylsulfonylamino)benzoyl]amino]benzamide;N-[4-(2-oxopiperidin-1-yl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;4-(propan-2-ylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]benzamide
SMILESCC(C)N(C(=O)c1ccc(NC(=O)c2ccc(NS(=O)(=O)C(C)C)cc2)cc1)C(C)C.CC(C)N(C(=O)c1cccc(NC(=O)c2ccc(NS(=O)(=O)C(C)C)cc2)c1)C(C)C.CC(C)S(=O)(=O)Nc1ccc(C(=O)Nc2ccc(N3CCCCC3=O)cc2)cc1.CC(C)S(=O)(=O)Nc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCCCC3)cc2)cc1.CC(C)S(=O)(=O)Nc1ccc(C(=O)Nc2cccc(S(=O)(=O)NC3CCCCC3)c2)cc1.CC(C)S(=O)(=O)Nc1ccc(C(=O)Nc2nnc(C(F)(F)F)s2)cc1
InChIInChI=1S/2C23H31N3O4S.2C22H29N3O5S2.C21H25N3O4S.C13H13F3N4O3S2/c1-15(2)26(16(3)4)23(28)19-9-11-20(12-10-19)24-22(27)18-7-13-21(14-8-18)25-31(29,30)17(5)6;1-15(2)26(16(3)4)23(28)19-8-7-9-21(14-19)24-22(27)18-10-12-20(13-11-18)25-31(29,30)17(5)6;1-16(2)31(27,28)24-19-13-11-17(12-14-19)22(26)23-20-9-6-10-21(15-20)32(29,30)25-18-7-4-3-5-8-18;1-16(2)31(27,28)24-20-10-8-17(9-11-20)22(26)23-18-12-14-21(15-13-18)32(29,30)25-19-6-4-3-5-7-19;1-15(2)29(27,28)23-18-8-6-16(7-9-18)21(26)22-17-10-12-19(13-11-17)24-14-4-3-5-20(24)25;1-7(2)25(22,23)20-9-5-3-8(4-6-9)10(21)17-12-19-18-11(24-12)13(14,15)16/h2*7-17,25H,1-6H3,(H,24,27);6,9-16,18,24-25H,3-5,7-8H2,1-2H3,(H,23,26);8-16,19,24-25H,3-7H2,1-2H3,(H,23,26);6-13,15,23H,3-5,14H2,1-2H3,(H,22,26);3-7,20H,1-2H3,(H,17,19,21)
InChIKeyBCWJUFAXRJDVPP-UHFFFAOYSA-N
MW2660.33 g/mol
LogP22.66
Rot. Bonds43

About N-[3-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-[di(propan-2-yl)carbamoyl]phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N,N-di(propan-2-yl)-3-[[4-(propan-2-ylsulfonylamino)benzoyl]amino]benzamide;N-[4-(2-oxopiperidin-1-yl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;4-(propan-2-ylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]benzamide

N-[3-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-[di(propan-2-yl)carbamoyl]phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N,N-di(propan-2-yl)-3-[[4-(propan-2-ylsulfonylamino)benzoyl]amino]benzamide;N-[4-(2-oxopiperidin-1-yl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;4-(propan-2-ylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]benzamide (PubChem CID 157309512) has the molecular formula C124H158F3N19O25S9 and a molecular weight of 2660.33 g/mol. Its IUPAC name is N-[3-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-[di(propan-2-yl)carbamoyl]phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N,N-di(propan-2-yl)-3-[[4-(propan-2-ylsulfonylamino)benzoyl]amino]benzamide;N-[4-(2-oxopiperidin-1-yl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;4-(propan-2-ylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]benzamide.

Molecular Properties

Compound NameN-[3-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-[di(propan-2-yl)carbamoyl]phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N,N-di(propan-2-yl)-3-[[4-(propan-2-ylsulfonylamino)benzoyl]amino]benzamide;N-[4-(2-oxopiperidin-1-yl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;4-(propan-2-ylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]benzamide
PubChem CID157309512
Molecular FormulaC124H158F3N19O25S9
Molecular Weight2660.33 g/mol
Exact Mass2657.91
IUPAC NameN-[3-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-[di(propan-2-yl)carbamoyl]phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N,N-di(propan-2-yl)-3-[[4-(propan-2-ylsulfonylamino)benzoyl]amino]benzamide;N-[4-(2-oxopiperidin-1-yl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;4-(propan-2-ylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]benzamide
SMILESCC(C)N(C(=O)c1ccc(NC(=O)c2ccc(NS(=O)(=O)C(C)C)cc2)cc1)C(C)C.CC(C)N(C(=O)c1cccc(NC(=O)c2ccc(NS(=O)(=O)C(C)C)cc2)c1)C(C)C.CC(C)S(=O)(=O)Nc1ccc(C(=O)Nc2ccc(N3CCCCC3=O)cc2)cc1.CC(C)S(=O)(=O)Nc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCCCC3)cc2)cc1.CC(C)S(=O)(=O)Nc1ccc(C(=O)Nc2cccc(S(=O)(=O)NC3CCCCC3)c2)cc1.CC(C)S(=O)(=O)Nc1ccc(C(=O)Nc2nnc(C(F)(F)F)s2)cc1
InChIInChI=1S/2C23H31N3O4S.2C22H29N3O5S2.C21H25N3O4S.C13H13F3N4O3S2/c1-15(2)26(16(3)4)23(28)19-9-11-20(12-10-19)24-22(27)18-7-13-21(14-8-18)25-31(29,30)17(5)6;1-15(2)26(16(3)4)23(28)19-8-7-9-21(14-19)24-22(27)18-10-12-20(13-11-18)25-31(29,30)17(5)6;1-16(2)31(27,28)24-19-13-11-17(12-14-19)22(26)23-20-9-6-10-21(15-20)32(29,30)25-18-7-4-3-5-8-18;1-16(2)31(27,28)24-20-10-8-17(9-11-20)22(26)23-18-12-14-21(15-13-18)32(29,30)25-19-6-4-3-5-7-19;1-15(2)29(27,28)23-18-8-6-16(7-9-18)21(26)22-17-10-12-19(13-11-17)24-14-4-3-5-20(24)25;1-7(2)25(22,23)20-9-5-3-8(4-6-9)10(21)17-12-19-18-11(24-12)13(14,15)16/h2*7-17,25H,1-6H3,(H,24,27);6,9-16,18,24-25H,3-5,7-8H2,1-2H3,(H,23,26);8-16,19,24-25H,3-7H2,1-2H3,(H,23,26);6-13,15,23H,3-5,14H2,1-2H3,(H,22,26);3-7,20H,1-2H3,(H,17,19,21)
InChIKeyBCWJUFAXRJDVPP-UHFFFAOYSA-N
XLogP22.66
TPSA630.67 Ų
H-Bond Donors14
H-Bond Acceptors28
Rotatable Bonds43
Heavy Atoms180
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002660.33
LogP ≤ 522.66
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1028

Analyze N-[3-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-[di(propan-2-yl)carbamoyl]phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N,N-di(propan-2-yl)-3-[[4-(propan-2-ylsulfonylamino)benzoyl]amino]benzamide;N-[4-(2-oxopiperidin-1-yl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;4-(propan-2-ylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

4-(tert-butylsulfonylamino)-N-[3-(cyclohexylcarbamoyl)phenyl]piperidine-1-carboxamide;4-(tert-butylsulfonylamino)-N-[4-(cyclohexylcarbamoyl)phenyl]piperidine-1-carboxamide;4-(tert-butylsulfonylamino)-N-[3-(cyclohexylsulfamoyl)phenyl]piperidine-1-carboxamide;4-(tert-butylsulfonylamino)-N-[4-(cyclohexylsulfamoyl)phenyl]piperidine-1-carboxamide;4-(tert-butylsulfonylamino)-N-(4-cyclopentyloxyphenyl)piperidine-1-carboxamide;4-(tert-butylsulfonylamino)-N-[4-(cyclopropylmethoxy)phenyl]piperidine-1-carboxamide;4-(tert-butylsulfonylamino)-N-(1,3-dimethyl-2,3-dihydro-1H-inden-5-yl)piperidine-1-carboxamide;4-(tert-butylsulfonylamino)-N-[2,3-dimethyl-4-[(2R,6S)-2,3,6-trimethylmorpholin-4-yl]phenyl]piperidine-1-carboxamide;4-(tert-butylsulfonylamino)-N-[3-[di(propan-2-yl)carbamoyl]phenyl]piperidine-1-carboxamide;4-(tert-butylsulfonylamino)-N-[4-[di(propan-2-yl)carbamoyl]phenyl]piperidine-1-carboxamide;4-(tert-butylsulfonylamino)-N-[3-fluoro-4-(trifluoromethyl)phenyl]piperidine-1-carboxamide;4-(tert-butylsulfonylamino)-N-[4-fluoro-3-(trifluoromethyl)phenyl]piperidine-1-carboxamide;4-(tert-butylsulfonylamino)-N-[4-(2-oxopiperidin-1-yl)phenyl]piperidine-1-carboxamide;4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]piperidine-1-carboxamide
CID 160941621
4-(benzenesulfonamido)-N-[4-(2-oxopyrrolidin-1-yl)phenyl]benzamide
CID 28578210
N,N-dimethyl-3-[[4-(2-oxopiperidin-1-yl)benzoyl]amino]benzamide
CID 51339093
3-[[3-(cyclohexylsulfamoyl)benzoyl]amino]benzoic acid
CID 1121769
4-(methoxysulfamoyl)-N-[3-(2-oxopyrrolidin-1-yl)phenyl]benzamide
CID 55704261
N-[3-[(2-chlorophenyl)sulfamoyl]phenyl]-4-(2-oxopyrrolidin-1-yl)benzamide
CID 4570058
N-cyclooctyl-4-(2-oxopyrrolidin-1-yl)benzenesulfonamide
CID 18096700
4-[[(3R)-1,1-dioxothiolan-3-yl]sulfamoyl]-N-[3-(2-oxopyrrolidin-1-yl)phenyl]benzamide
CID 26002695
3-[[4-(cyclopropylsulfamoyl)benzoyl]amino]-N,N-dimethylbenzamide
CID 30379406
3-(tert-butylsulfamoyl)-N-[4-(2-oxopyrrolidin-1-yl)phenyl]benzamide
CID 8747935
N,N-dimethyl-4-[[4-(2-oxopyrrolidin-1-yl)phenyl]sulfonylamino]benzamide
CID 24580878
N-cyclohexyl-3-[[4-(propan-2-ylsulfonylamino)phenyl]methylamino]benzenesulfonamide
CID 70939182

Frequently Asked Questions

What is the IUPAC name of N-[3-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-[di(propan-2-yl)carbamoyl]phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N,N-di(propan-2-yl)-3-[[4-(propan-2-ylsulfonylamino)benzoyl]amino]benzamide;N-[4-(2-oxopiperidin-1-yl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;4-(propan-2-ylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]benzamide?
The IUPAC name of N-[3-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-[di(propan-2-yl)carbamoyl]phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N,N-di(propan-2-yl)-3-[[4-(propan-2-ylsulfonylamino)benzoyl]amino]benzamide;N-[4-(2-oxopiperidin-1-yl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;4-(propan-2-ylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]benzamide (CID 157309512) is N-[3-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-[di(propan-2-yl)carbamoyl]phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N,N-di(propan-2-yl)-3-[[4-(propan-2-ylsulfonylamino)benzoyl]amino]benzamide;N-[4-(2-oxopiperidin-1-yl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;4-(propan-2-ylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]benzamide.
What is the SMILES notation for N-[3-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-[di(propan-2-yl)carbamoyl]phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N,N-di(propan-2-yl)-3-[[4-(propan-2-ylsulfonylamino)benzoyl]amino]benzamide;N-[4-(2-oxopiperidin-1-yl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;4-(propan-2-ylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]benzamide?
The canonical SMILES for N-[3-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-[di(propan-2-yl)carbamoyl]phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N,N-di(propan-2-yl)-3-[[4-(propan-2-ylsulfonylamino)benzoyl]amino]benzamide;N-[4-(2-oxopiperidin-1-yl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;4-(propan-2-ylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]benzamide is CC(C)N(C(=O)c1ccc(NC(=O)c2ccc(NS(=O)(=O)C(C)C)cc2)cc1)C(C)C.CC(C)N(C(=O)c1cccc(NC(=O)c2ccc(NS(=O)(=O)C(C)C)cc2)c1)C(C)C.CC(C)S(=O)(=O)Nc1ccc(C(=O)Nc2ccc(N3CCCCC3=O)cc2)cc1.CC(C)S(=O)(=O)Nc1ccc(C(=O)Nc2ccc(S(=O)(=O)NC3CCCCC3)cc2)cc1.CC(C)S(=O)(=O)Nc1ccc(C(=O)Nc2cccc(S(=O)(=O)NC3CCCCC3)c2)cc1.CC(C)S(=O)(=O)Nc1ccc(C(=O)Nc2nnc(C(F)(F)F)s2)cc1.
What is the InChIKey of N-[3-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-[di(propan-2-yl)carbamoyl]phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N,N-di(propan-2-yl)-3-[[4-(propan-2-ylsulfonylamino)benzoyl]amino]benzamide;N-[4-(2-oxopiperidin-1-yl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;4-(propan-2-ylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]benzamide?
The InChIKey is BCWJUFAXRJDVPP-UHFFFAOYSA-N. The full InChI is InChI=1S/2C23H31N3O4S.2C22H29N3O5S2.C21H25N3O4S.C13H13F3N4O3S2/c1-15(2)26(16(3)4)23(28)19-9-11-20(12-10-19)24-22(27)18-7-13-21(14-8-18)25-31(29,30)17(5)6;1-15(2)26(16(3)4)23(28)19-8-7-9-21(14-19)24-22(27)18-10-12-20(13-11-18)25-31(29,30)17(5)6;1-16(2)31(27,28)24-19-13-11-17(12-14-19)22(26)23-20-9-6-10-21(15-20)32(29,30)25-18-7-4-3-5-8-18;1-16(2)31(27,28)24-20-10-8-17(9-11-20)22(26)23-18-12-14-21(15-13-18)32(29,30)25-19-6-4-3-5-7-19;1-15(2)29(27,28)23-18-8-6-16(7-9-18)21(26)22-17-10-12-19(13-11-17)24-14-4-3-5-20(24)25;1-7(2)25(22,23)20-9-5-3-8(4-6-9)10(21)17-12-19-18-11(24-12)13(14,15)16/h2*7-17,25H,1-6H3,(H,24,27);6,9-16,18,24-25H,3-5,7-8H2,1-2H3,(H,23,26);8-16,19,24-25H,3-7H2,1-2H3,(H,23,26);6-13,15,23H,3-5,14H2,1-2H3,(H,22,26);3-7,20H,1-2H3,(H,17,19,21).
What are the key properties of N-[3-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-[di(propan-2-yl)carbamoyl]phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N,N-di(propan-2-yl)-3-[[4-(propan-2-ylsulfonylamino)benzoyl]amino]benzamide;N-[4-(2-oxopiperidin-1-yl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;4-(propan-2-ylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]benzamide?
N-[3-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-[di(propan-2-yl)carbamoyl]phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N,N-di(propan-2-yl)-3-[[4-(propan-2-ylsulfonylamino)benzoyl]amino]benzamide;N-[4-(2-oxopiperidin-1-yl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;4-(propan-2-ylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]benzamide has a molecular weight of 2660.33 g/mol, XLogP of 22.66, 43 rotatable bonds, 14 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-(cyclohexylsulfamoyl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N-[4-[di(propan-2-yl)carbamoyl]phenyl]-4-(propan-2-ylsulfonylamino)benzamide;N,N-di(propan-2-yl)-3-[[4-(propan-2-ylsulfonylamino)benzoyl]amino]benzamide;N-[4-(2-oxopiperidin-1-yl)phenyl]-4-(propan-2-ylsulfonylamino)benzamide;4-(propan-2-ylsulfonylamino)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]benzamide is sourced from PubChem (CID 157309512), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).